INSIGHTS ON DRUG DEVELOPMENT

• Best-In-Class Nanodevelopment Capabilities

  A highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers.

• Evaluating Compound Toxicity Effects On Healthy Intestinal Organoids

  3D organoids enhance drug toxicity prediction and are crucial for anti-cancer drug development. Examine a method using 3D mouse intestinal organoids that aims to provide vital data on intestinal toxicity.

• Simplify Process Scale-Up With An Innovative Single-Use Bioreactor

  Consistent cell growth and protein yields from 5 L to 5,000 L show how a unified bioreactor design can simplify scale-up, reduce risk, and accelerate upstream process development in bioproduction.

• Cell Culture Media Filtration: Evaluating Cell Culture Performance

  Cell culture performance remained consistent across PES and PVDF filters, even under worst-case filtration conditions. Discover a practical framework for evaluating membrane impact on CHO cell growth.

• A Human-Relevant Model Of The Liver Sinusoid

  11/7/2024

  This organ-on-a-chip model minimizes drug absorption while maintaining the essential architecture. Explore the specifications of this product engineered to model the human liver.

• Formulation Development Of Enterically Protected Spray Dried Dispersions

  11/17/2025

  Adrulipase spray-dried dispersions were evaluated to create an orally delivered, enteric-protected enzyme. The lead formulation provided the best acid protection, rapid release, and stability.

• Optimization And Scale-Up Of A Plasmid DNA Production Process

  9/30/2025

  Optimizing pDNA production in E. coli requires strategic media selection and scale-up planning. Explore a study that identifies ideal conditions for high-yield manufacturing.

• How To Power MRD Assessment And Multi-Cancer Detection Research

  6/25/2026

  New advances in MCED and MRD monitoring are transforming cancer care. Fueled by NGS insights, see how these approaches are shifting treatment decisions toward more proactive strategies.

• Extractables And Leachables: Setting Up Early For Success With Your CDMO

  10/2/2024

  Discover insights tailored specifically for drug product researchers and manufacturers, offering key knowledge on extractables, leachables, and effective implementation strategies.